We aim to build support for expanding HIV treatment to save lives and prevent the spread of the virus. Building on our experience treating HIV, we are introducing new treatment approaches and using our expertise to fight for lower medicine prices.
Untangling the Web of Antiretroviral Price Reductions
Our report finds that prices of older HIV drugs continue to decline, while newer drugs remain largely priced out of reach. This is in large part because pharmaceutical corporations maintain monopolies that block price-lowering generic competition.
HIV/AIDS: The Issues
HIV status: Undetectable
How Viral Load testing helped 47 year old Marita Saka who is HIV positive to adjust and improve her treatment...